Mid-Day Market Update: Dow Jumps 100 Points; Spero Therapeutics Shares Plunge

U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 100 points on Tuesday.

The Dow traded up 0.35% to 33,178.65 while the NASDAQ rose 0.01% to 12,537.98. The S&P also rose, gaining, 0.54% to 4,177.90.

Also check this: Executives Buy Around $1.6M Of 4 Penny Stocks


Leading and Lagging Sectors


Energy shares climbed 2.5% on Tuesday. Meanwhile, top gainers in the sector included TETRA Technologies, Inc. TTI, up 16% and CVR Energy, Inc. CVI up 13%.


In trading on Tuesday, consumer discretionary shares fell by 0.2%.


Top Headline


Pfizer Inc. PFE posted upbeat results for its first quarter on Tuesday.


Pfizer posted quarterly adjusted earnings of $1.62 per share, exceeding analysts’ estimates of $1.50 per share. The company’s quarterly sales came in at $25.70 billion, versus expectations of $23.95 billion.

Pfizer revised its FY22 adjusted EPS guidance to $6.25-$6.45 to reflect $0.11 negative impact for accounting policy change. The company also sees sales of $98 billion to $102 billion.


Equities Trading UP


Belite Bio, Inc BLTE shares shot up 28% to $11.39. The FDA has granted Fast Track Designation to Belite Bio’s LBS-008 for Stargardt disease (STGD1).


Shares of Sonoma Pharmaceuticals, Inc. SNOA got a boost, shooting 33% to $3.5316 after the company and its partner MicroSafe Group DMCC received EPA approval for Nanocyn as a hospital-grade disinfectant.


Enovix Corporation ENVX shares were also up, gaining 21% to $10.83. Enovix announced initial smartwatch battery order from leading global consumer electronics company.


Equities Trading DOWN

Spero Therapeutics, Inc. SPRO shares tumbled 60% to $2.0180. Spero Therapeutics will defer current commercialization activities for tebipenem HBr based on feedback from a recent Late Cycle Meeting (LCM) with the FDA.


Shares of Chegg, Inc. CHGG were down 30% to $17.48 after the company reported Q1 earnings results and issued Q2 and FY22 sales guidance below analyst estimates.


Kymera Therapeutics, Inc. KYMR was down, falling 26% to $24.13 after the company reported worse-than-expected Q1 EPS and sales results.


Also check out: 4 Stocks Under $3 Insiders Are Aggressively Buying


Commodities

In commodity news, oil traded down 0.8% to $104.29, while gold traded up 0.6% to $1,874.80.


Silver traded up 1% Tuesday to $22.815 while copper rose 0.5% to $4.2895.



Euro zone


European shares were mostly higher today. The eurozone’s STOXX 600 gained 0.28%, London’s FTSE 100 fell 0.05% and Spain’s IBEX 35 Index rose 1.62%. The German DAX gained 0.26%, French CAC 40 gained 0.40% and Italy’s FTSE MIB Index climbed 1.33%.

The unemployment rate in the Eurozone dropped to a record low of 6.8% in March from a revised 6.9% in February, while annual producer inflation rose to record high of 36.8% in March from a revised 31.5 percent in February. UK’s manufacturing PMI increased to 55.8 in April from a preliminary of 55.3, while unemployment rate in Germany remained at 5%.


Economics


The Federal Open Market Committee will begin its two-day policy meeting today.


Factory orders rose 2.2% month-over-month to $557.3 billion in March.


The number of job openings increased by 205,000 from a month ago to a series high of 11.549 million in March.


Check out this: Executives Buy More Than $90M Of 4 Stocks


COVID-19 Update

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 83,170,400 cases with around 1,021,080 deaths. India confirmed a total of at least 43,085,160 cases and 523,880 deaths, while Brazil reported over 30,460,990 COVID-19 cases with 663,650 deaths. In total, there were at least 514,034,340 cases of COVID-19 worldwide with more than 6,263,580 deaths.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsPenny StocksEurozoneCommoditiesSmall CapGlobalIntraday UpdateMarketsMid-Day Market Update
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!